Youll earn points on this purchase automatically when logged in.
The results reported a 6.0%, 6.8%, 9.1%, 9.7%, and 10.8% decrease in body weight for the groups receiving cagrilintide in doses of 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg, respectively [1]
The Obesity Medicine Association does not recommend using compounded GLP-1 medication, but they do offer access to treatment to those without insurance coverage
130,132 Although the precise mechanisms remain uncertain, effects on the liver and direct actions on the gut, including slowing of gastric emptying, have been proposed
Persistent symptoms can sometimes indicate that a different treatment might be a better fit for your body
doi:10.1016/j.tips.2009.07.002